Abstract:The considerable increase of investment in research and development by the pharmaceutical industry over the past three decades has not added the number of approved new drugs. An important issue ignored by drug discovery practice is the multi-dimensional interaction network between drugs and their targets. Thus, it is essential to view drug actions through the lens of network biology. In the current study, based on the co-expression network of transcription factors and their downstream genes, we proposed a novel approach, called causal co-expression method with module analysis, to screen drugs with specific target and fewer side effects. We presented a causal co-expression method with module analysis and it could be used in analyzing the microarray data of different drug candidates. At first, the differential wiring value (DW) was calculated to find some causal transcription factors (TFs) by combining with differential expression genes in the regulated networks. After the discovery of the causal TFs, co-expression module analysis method was applied to mine molecular pharmacology pathways around these causal TFs at molecular level. We applied our methods to two drug candidates, Argyrin A and Bortezomib, both with anti-cancer activities. We first obtained some differentially expressed transcription factors of cells treated with Argyrin A or Bortezomib. Nearly all these transcription factors are associated with the tumor suppressor protein p27kip1. Furthermore, module analysis showed that Bortezomib inhibited tumor growth not specifically by cell cycle and cell proliferation pathway, but through many basic metabolic processes which result in cell toxicity. In contrast, Argyrin A had influence on cell cycle, and was involved in DNA damage repair at the same time, showing that Argyrin A was a more suitable drug for anti-cancer treatment. Our study revealed that the causal co-expression method with module analysis was effective and can be used as a tool to evaluate drug candidates.

Application of cDNA microarray in the mechanism analysis of drug

The Application of Cdna Microarrays Technology in Mechanism of Drug

Application of DNA Microarray Technologies in Neurotoxicology Research

APPLICATION OF DIFFERENT MICROARRAY ANALYSIS METHODS IN PHARMACOLOGICAL MECHANISM RESEARCH

Gcncchip Technology and Its Application in Pharmacology

Screening the Human Pancreatic Cancer-Associated Genes by Cdna Microarray

Use of three-color cDNA microarray experiments to assess the therapeutic and side effect of drugs

Cdna Microarray Technique in Screening Primary Drug Resistance-Related Genes of Human Malignant Glioma

Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray.

Cdna Microarray in Analysis of Pancreatic Cancer-Related Genes

DNA Microarray Analysis of Gene Expression Profiles in Pancreatic Carcinoma

Effect of basil polysaccharide on rat model bearing NuTu- 19 cells

Application of DNA microarray technology in immunological research and its inspiration to researches on traditional Chinese medicine

Study on Metastasis-Associated Gene in Carcinoma by Cdna Microarray

Causal Co-Expression Method with Module Analysis to Screen Drugs with Specific Target.

Differentially Expressed Genes in Normal Breast Tissue and Breast Cancer Tissue by Cdna Microarray

THE ESTABLISHMENT OF cDNA MICROARRAY ABOUT PARTS OF SIGNAL TRANSDUCTION PATHWAY IN TREE SHREWS

Microarray analysis of cardiovascular diseases.

Analysis of Gene Expression Profiles in Pancreatic Carcinoma by Using Cdna Microarray.

Analysis on cDNA Microarray during the Process of Myocardial Infarction Treated by Dan Hong Injection

Gene Chip Technology and Its Application in Investigation of Anticancer Medicament